Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03653936 · ClinicalTrials.gov registry record
Neuro-ocular Baselines in a Sports Setting
A clinical trial, sponsored by Rebiscan.
- Completed
- Registry status
- 63
- Enrollment target
NCT03653936 is a clinical trial that has completed, run by Rebiscan. The registered enrollment target is 63 participants.
The verdict
NCT03653936 has completed, sponsored by Rebiscan.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
Rebion (Rebiscan, Inc) has developed a noninvasive, handheld device that uses retinal birefringence scanning (RBS) to rapidly assess eye fixation and retinal integrity in adults and children. The proprietary technology uses a scanned annulus of polarized laser light to create a signature that confirms central fixation within seconds. The project described herein aims to provide accurate assessment of brain dysfunction in TBI (Traumatic Brain Injury) patients through the use of the developed device, which is called the Head and Intraocular Trauma Test (HITT) device.
Interventions
- DEVICE HITT device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2018-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03653936
The ClinicalTrials.gov registry entry for NCT03653936 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rebiscan, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HITT device is the first listed.
NCT03653936 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03653936 about?
NCT03653936 is a clinical study titled "Neuro-ocular Baselines in a Sports Setting". Rebion (Rebiscan, Inc) has developed a noninvasive, handheld device that uses retinal birefringence scanning (RBS) to rapidly assess eye fixation and retinal integrity in adults and children. The proprietary technology uses a scanned annulus of polarized laser light to create a signature that confir...
What is the current status of trial NCT03653936?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2018-04-01. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT03653936?
The interventions under investigation include: HITT device (DEVICE).
Who is sponsoring clinical trial NCT03653936?
This trial is sponsored by Rebiscan, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.